Shares of Netflix, Inc. NFLX surged in pre-market trading following the company’s strong fourth-quarter earnings report.
Netflix reported fourth-quarter revenue of $8.83 billion, marking a 12.5% year-over-year increase, surpassing analysts’ expectations. The company’s fourth-quarter earnings per share stood at $2.11, slightly below the Street’s estimate of $2.21.
Remarkably, the streaming giant added 13.12 million net paid subscribers in the fourth quarter.
As a result, Netflix shares soared by 10.2% to $542.48 in pre-market trading.
In addition to Netflix, several other stocks experienced significant movement in pre-market trading.
Winners
- Getaround, Inc. GETR surged 50.7% to $0.2771, following the announcement of a new debt facility.
- Evaxion Biotech A/S EVAX gained 43.2% to $7.15 after a 13G filing revealed Merck & Co had acquired an 11.4% stake in the company.
- VS MEDIA Holdings Limited VSME saw a 31.7% surge to $0.4318, following a 3% gain on Tuesday.
- Zoomcar Holdings, Inc. ZCAR gained 18.1% to $3.98 after appointing Adarsh Menon as President.
- RedHill Biopharma Ltd. RDHL gained 17.8% to $1.05, propelled by the granting of U.S. Patent #11878011.
- Nyxoah S.A. NYXH surged 17.7% to $6.59, following a 20% surge on Tuesday.
- Greenidge Generation Holdings Inc. GREE climbed 15.7% to $4.10, rebounding from a more than 10% decline on Tuesday.
- Cadrenal Therapeutics, Inc. CVKD gained 10.7% to $1.14.
- Ensysce Biosciences, Inc. ENSC saw an 8.6% rise to $1.51, following a 22% gain on Tuesday, spurred by the announcement of FDA Breakthrough Therapy Designation for PF614-MPAR.
Losers
- Meta Materials Inc. MMAT saw a 16.2% decline to $0.0560 after announcing a 1-for-100 reverse stock split.
- BlackBerry Limited BB fell 11% to $3.16 following the announcement of a proposed private offering of $160 million of convertible senior notes.
- vTv Therapeutics Inc. VTVT declined 9.4% to $8.48.
- ETAO International Co., Ltd. ETAO fell 8.9% to $0.2010, following a 20% dip on Tuesday.
- Diversified Energy Company PLC DEC declined 8.9% to $11.74.
- Sonoma Pharmaceuticals, Inc. SNOA dropped 8% to $0.1574 after announcing the launch of Lumacyn Clarifying Mist direct to consumers for over-the-counter use in the US.
- Opthea Limited OPT saw a 7.9% decline to $2.44.
- HWH International Inc. HWH shares suffered a 7.3% decline to $1.78, following a more than 23% gain on Tuesday.
- FaZe Holdings Inc. FAZE declined 6.9% to $0.2978, after a 107% surge on Tuesday when the company announced sponsorship for its Counter-Strike team.
- Texas Instruments Incorporated TXN shares dipped 3.7% to $167.88 after reporting fourth-quarter financial results.
Investors are advised to closely monitor these pre-market movers for potential opportunities.
